The largest database of trusted experimental protocols

Bio plex pro human cytokine assay

Manufactured by Bio-Rad
Sourced in United States, Germany

The Bio-Plex Pro Human Cytokine Assay is a multiplex immunoassay designed to measure multiple cytokines, chemokines, and growth factors simultaneously in a single well of a 96-well plate. The assay utilizes magnetic beads coated with specific antibodies for each analyte, allowing for the detection and quantification of up to 45 different human proteins in a single sample.

Automatically generated - may contain errors

35 protocols using bio plex pro human cytokine assay

1

Multiplex Biometric Immunoassay for Cytokine Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
A standard multiplex biometric immunoassay was utilized to assay cytokines (Bio-Plex Pro human cytokine assay; Bio-Rad, Hercules, CA). Briefly, diluted serum samples were incubated with antibody-coupled beads corresponding to the various cytokines. After performing washes to remove unbound protein, the beads were incubated with a biotinylated secondary antibody. The reaction mixture was then detected by the addition of streptavidin-phycoerythrin (streptavidin-PE). Assays were measured by detection of the fluorescent reporter signal and identification of beads on a Bio-Plex 200 system, and data were analyzed using the associated Bio-Plex Manager software version 4.1.1 (Bio-Rad).
+ Open protocol
+ Expand
2

Multiplex Cytokine Profiling of Subjects

Check if the same lab product or an alternative is used in the 5 most similar protocols
We performed a multiplex cytokine bead assay blindly and in parallel using the Bio-plex Pro Human Cytokine assay (Bio-Rad, Hercules, CA) and Milliplex MAP Human Cytokine/Chemokine panel 1 (Millipore, Billerica, MA) according to the manufacturers’ instructions as described previously.[15 (link)] The subjects’ baseline demographic characteristics were compared using Fisher's exact test for discrete variables and the Wilcoxon test for continuous variables. The Kruskal–Wallis test followed by Dunn's multiple comparisons test was used to compare cytokine levels between groups. To rank the cytokine levels, we performed a multivariate classification algorithm termed random forest analysis (RFA),[16 ] using the R package RandomForest (http://cran.r-project.org/web/packages/randomForest/) ver. 4.6–12 software, as previously described.[17 (link)]
+ Open protocol
+ Expand
3

Multiplex Cytokine Quantification in Saliva

Check if the same lab product or an alternative is used in the 5 most similar protocols
Luminex xMAP technology for multiplexed quantification of cytokines in the saliva samples was used. The multiplexing analysis was performed using the Bio-Plex Luminex™ 200 system (Bio-Rad Laboratories, Hercules, CA, USA). Cytokines were simultaneously measured using a Bio-Plex Pro Human Cytokine Assay (Bio-Rad Laboratories, Hercules, CA, USA) according to the manufacturer’s protocol.
+ Open protocol
+ Expand
4

Multiplex Cytokine Profiling in PBMC Cultures

Check if the same lab product or an alternative is used in the 5 most similar protocols
Bio-Plex Pro Human Cytokine Assay (Bio-Rad, #12007283) was used to measure 48 cytokines and chemokines in PBMC culture media, as per manufacturer’s instructions. Samples were prepared at 1:4 dilution, and a total of 10 standards were used per cytokine to generate standard curves. The plate was read on MAGPIX (Luminex xMAP) and data were analysed with Bio-Plex Manager software (version 6.0).
+ Open protocol
+ Expand
5

Cytokine Profiling of Macrophage Response to Nanomaterials

Check if the same lab product or an alternative is used in the 5 most similar protocols
HMDM (106 cells/ml) were exposed to the nanomaterials at the indicated concentrations for 24 h. Cell supernatant were then collected, centrifuged at 15.000 g for 5 min to remove nanomaterials and cell debris and stored at −80 °C. Supernatants were never refrozen. Chemokines were quantified by using a Bio-Plex Pro Human Cytokine Assay (Bio-Rad) and Bio-Plex® system and software following the manufacturer’s instructions74 (link). The cytokine standards were reconstituted in RPMI-1640 cell culture medium supplemented with 10% FBS. For NF-κB inhibition studies, HMDM were pre-exposed to Bay 11-7082 (10 µM) for 1 h. After pre-incubation, the inhibitor was removed from the medium and cells were exposed to SWCNTs.
+ Open protocol
+ Expand
6

Cytokine and DPP4 Profiling in Sera

Check if the same lab product or an alternative is used in the 5 most similar protocols
The collected sera were analyzed for inflammatory cytokines other than human IL-26 using Bio-Plex Pro Human Cytokine Assay (Bio-Rad Laboratories, Hercules, CA). IL-26 was assayed using Human IL-26 ELISA Kit (CUSABIO, Hubei, China). Assay for soluble CD26/dipeptidyl peptidase IV (DPP4) was developed in our laboratory (34 (link)). All samples were run in triplicates.
+ Open protocol
+ Expand
7

Multiplex Cytokine Quantification

Check if the same lab product or an alternative is used in the 5 most similar protocols
IL-1β and IL-6 cytokines release was analyzed in the culture supernatants using commercially available Bio-Plex-Pro Human Cytokine assay (BioRad Laboratories, Hercules, CA) according to the manufacturer's protocol. Sample were acquired by a Bio-Plex 200 system and after setting up the calibration the cytokines concentration were performed using the Bio-Plex Manager software v5.0 (BioRad).
+ Open protocol
+ Expand
8

Comprehensive Cytokine Profiling Using Multiplex Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
We performed a multiplex cytokine bead assay blindly and in parallel using the Bio-plex Pro Human Cytokine assay (Bio-Rad, Hercules, CA) and Milliplex MAP Human Cytokine/Chemokine panel 1 (Millipore, Billerica, MA) according to the manufacturers’ instructions. We were able to further analyze 29 of the 45 cytokines: IL-1β, IL-1 receptor antagonist (IL-1RA), IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IL-12 (p40), IL-12 (p70), IL-17, IL-18, TNF-α, interferon-α (IFN-α), IFN-γ, granulocyte macrophage colony stimulating factor, basic granulocyte colony stimulating factor (G-CSF), vascular endothelial growth factor, soluble CD54 (sCD54), sCD106, fibroblast growth factor 2, CCL2 (monocyte chemoattractant protein-1/MCAF), CCL3 (macrophage inflammatory protein-1a), CCL4 (macrophage inflammatory protein-1b), CCL22 (human macrophage-derived chemokine), CXCL1 (growth-regulated protein alpha precursor), CXCL10 (IFN-γ inducible protein 10), and CX3CL1 (fractalkine).
+ Open protocol
+ Expand
9

Inflammasome Activation in iPS-Derived Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
iPS-MLs or iPS-MPs were harvested as described above and seeded into 96-well plates at 5 × 104 cells per well. When indicated, cells were pretreated with ABT-751 (10 µM; Sigma-Aldrich), CA4P (10 µM; Sigma-Aldrich), MCC950 (10 µM; Sigma-Aldrich), and colchicine (100 ng/ml; Sigma-Aldrich) 30 min before LPS priming or with 2BP (20 µM; Sigma-Aldrich) and bryostatin (0.1 µM; Sigma-Aldrich) 24 h before harvest. For inflammasome activation, cells were primed with LPS (1 µg/ml) for 4 h and treated with UCN-01 (10 µM; Sigma-Aldrich), nigericin (10 µM; Sigma-Aldrich), or purified flagellin from Salmonella typhimurium (InvivoGen) in DOTAP liposomes (Roche; IC-FLA; 6 µg DOTAP/1 µg FLA-ST) for an additional 2 h, after which the supernatants were collected. For TcdA stimulation, TcdA (1 µg/ml; List Biological Laboratories) was added after 2 h of LPS priming (1 µg/ml) and the supernatants were collected 4 h later. For AIM2 inflammasome activation, poly (dA; dT)/Lyovec (1 µg/ml; InvivoGen) was added along with LPS priming (1 µg/ml), and the supernatants were collected 4 h later. The IL-1β, IL-18, and IL-6 concentrations were measured using the Bio-Plex Pro Human Cytokine Assay (BioRad).
+ Open protocol
+ Expand
10

Biomarker Quantification in Plasma

Check if the same lab product or an alternative is used in the 5 most similar protocols
All ELISA assays were performed using commercially available ELISA Kits according to the manufacturer’s instructions. Concentrations of IGF-1 and IGF-2 were analyzed in the plasma samples using ELISA Kits E20 and E30 (Mediagnost, Reutlingen, Germany). Cortisol was determined with EIA 1887 (DRG Instruments GmbH, Marburg, Germany) and cross validated with LC-MS/MS revealing a correlation coefficient of r = 0.926 (Spearman correlation). Plasma concentrations of IL-2 were analyzed by Bioglobe GmbH (Hamburg, Germany) using the Bio-Plex Pro™ Human Cytokine Assay (Biorad, Hercules, U.S.A.). Serum amyloid A (SAA) was determined using a Phase SAA ELISA kit (Tridelta Development Ltd., Maynooth, Ireland).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!